pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,689 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: recall×type: approval×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06871579: Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07530588: Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

    Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07474688: Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure

    Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Uterine Fibroids (Leiomyoma)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

    Sponsor: Cancer Research Antwerp. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01969227: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

    Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE2. Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545461: Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

    Sponsor: Donald Wesson. Phase: NA. Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06037161: Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

    Sponsor: Case Western Reserve University. Phase: NA. Conditions: Recession, Gingival

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506486: Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study)

    Sponsor: Universitas Padjadjaran. Phase: NA. Conditions: Stroke (Subacute)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07336186: The Effect of Virtual Reality-Based Relaxation on Breast Milk Volume and Breastfeeding Self-Efficacy in Mothers of Preterm Infants

    Sponsor: Kocaeli University. Phase: NA. Conditions: Lactation, Breastfeeding, Premature Birth, Maternal Stress, Self-Efficacy

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05089786: Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)

    Sponsor: InSightec. Phase: NA. Conditions: Essential Tremor, Neurology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07634770: Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

    Sponsor: Sam Chun Dang Pharm. Co. Ltd.. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07610473: A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

    Sponsor: Draig Therapeutics Ltd. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619469: Motion Sickness Severity and Sensorimotor Performance

    Sponsor: Istinye University. Phase: . Conditions: Motion Sickness, Somatosensory Disorders, Dizziness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06054269: Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

    Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07121283: Artificial Intelligence Assisted Bone Age Assessment

    Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02530983: Mayo Clinic Upper Digestive Disease Survey

    Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04002141: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

    Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06334354: A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06105541: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06940141: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07435441: Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

    Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997094: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

    Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06665594: Effect of TXA on Reducing Bruising After Filler Injection

    Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05687266: Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05558566: Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

    Sponsor: Yale University. Phase: NA. Conditions: Tourette Syndrome in Adolescence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01625351: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07570329: Human Milk Oligosaccharides, Gut Bifidobacterium, Vitamin D, and Infant Immunity

    Sponsor: Hasanuddin University. Phase: . Conditions: Healhty

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05203731: Level of Physical Activity and Fear Learning

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06156202: Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Long COVID, Long Covid19, Dyspnea, Orthostasis, Cognitive Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04857502: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04850053: Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

    Sponsor: Capital Medical University. Phase: . Conditions: Alzheimer's Disease

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03799445: Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Basaloid Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Posterior Tongue Squamous Cell Carcinoma, Soft Palate Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Tonsillar Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06367972: A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: OligoProgressive Metastatic Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06907472: Diabetes Management for Primary Healthcare Centers.

    Sponsor: University of Abuja. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04310995: Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

    Sponsor: Ruijin Hospital. Phase: PHASE4. Conditions: Coronary Artery Bypass Graft, Radial Artery Grafts, Antispastic Therapy, Pilot Study

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07467395: Evaluation of Augmented Reality on Dental Pain and Anxiety During Primary Molars' Extraction

    Sponsor: Sara Hazem Mohamed Rabie. Phase: NA. Conditions: Dental Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05841095: Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104

    Sponsor: Erasmus Medical Center. Phase: PHASE1. Conditions: Chronic Hepatitis b

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04980495: An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

    Sponsor: argenx. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis, MG - Myasthenia Gravis, gMG

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03289039: Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07403539: Speech Learning and Speech Production in Parkinson's Disease

    Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06464939: Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

    Sponsor: HysensBio Co., Ltd. Phase: PHASE2. Conditions: Dentin Hypersensitivity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07298239: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Prostate Cancer Castration-resistant Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06619639: Feasibility of a Social-emotional Learning Curriculum in an After-school Program for Youth

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Feasibility Studies, Efficacy of Intervention, Social Emotional Learning

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491939: Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)

    Sponsor: Dorothy House Hospice. Phase: . Conditions: Inflammatory Arthritis, Palliative Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07198139: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus

    Sponsor: Cocrystal Pharma, Inc.. Phase: PHASE1. Conditions: Norovirus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06510439: Need to be Needed (N2BN) Intervention

    Sponsor: Temple University. Phase: NA. Conditions: Loneliness, Social Isolation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05897593: Clinical Feasibility & Validation of the Augmented Reality GlenxRose Acquired Brain Injury Rehabilitation Programs

    Sponsor: University of Alberta. Phase: NA. Conditions: Acquired Brain Injury, Stroke, Traumatic Brain Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01150721: Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection

    Sponsor: National Institutes of Health Clinical Center (CC). Phase: . Conditions: Mycobacterium Infections, Non-tuberculous

    full page →ctgov ↗
    ← prev
    page 65 of 94
    next →